Regencell Bioscience [RGC] vs Prestige Consumer [PBH] Detailed Stock Comparison

Regencell Bioscience

NASDAQ

Prestige Consumer

NYSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Regencell Bioscience wins in 4 metrics, Prestige Consumer wins in 8 metrics, with 0 ties. Prestige Consumer appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Regencell Bioscience	Prestige Consumer	Better
P/E Ratio (TTM)	N/A	17.92	N/A
Price-to-Book Ratio	960.00	2.07	Prestige Consumer
Debt-to-Equity Ratio	0.01	56.91	Regencell Bioscience
PEG Ratio	N/A	16.12	N/A
EV/EBITDA	-1,664.45	12.51	Regencell Bioscience
Profit Margin (TTM)	0.00%	18.86%	Prestige Consumer
Operating Margin (TTM)	0.00%	34.03%	Prestige Consumer
EBITDA Margin (TTM)	N/A	34.03%	N/A
Return on Equity	-47.77%	12.30%	Prestige Consumer
Return on Assets (TTM)	-30.65%	6.50%	Prestige Consumer
Free Cash Flow (TTM)	$-4.01M	$243.29M	Prestige Consumer
1-Year Return	5,863.64%	-5.19%	Regencell Bioscience
Price-to-Sales Ratio (TTM)	N/A	3.33	N/A
Enterprise Value	$6.64B	$4.75B	Regencell Bioscience
EV/Revenue Ratio	N/A	4.17	N/A
Gross Profit Margin (TTM)	N/A	57.34%	N/A
Revenue per Share (TTM)	N/A	$23	N/A
Earnings per Share (Diluted)	$-0.01	$4.29	Prestige Consumer
Beta (Stock Volatility)	2.19	0.43	Prestige Consumer

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Regencell Bioscience vs Prestige Consumer Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Regencell Bioscience	3.31%	-6.08%	-4.23%	24.01%	13,020.00%	9,992.31%
Prestige Consumer	0.60%	-0.90%	-13.52%	-25.39%	-23.71%	-16.38%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Regencell Bioscience	5,863.64%	1,443.53%	4,585.71%	4,585.71%	4,585.71%	4,585.71%
Prestige Consumer	-5.19%	14.08%	74.66%	36.30%	774.70%	420.34%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Regencell Bioscience (RGC): View Full Stock Overview

Prestige Consumer (PBH): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Regencell Bioscience vs Prestige Consumer

Metric	RGC	PBH
Market Information
Market Cap i	$6.65B	$3.79B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	311,130	406,280
90 Day Avg. Volume i	1,546,083	411,937
Last Close	$13.12	$64.99
52 Week Range	$0.09 - $83.60	$62.95 - $90.04
% from 52W High	-84.31%	-27.82%
All-Time High	$950.00 (May 30, 2025)	$90.04 (Mar 10, 2025)
% from All-Time High	-98.62%	-27.82%
Growth Metrics
Quarterly Revenue Growth	N/A	0.07%
Quarterly Earnings Growth	N/A	0.01%
Financial Health
Profit Margin (TTM) i	0.00%	0.19%
Operating Margin (TTM) i	0.00%	0.34%
Return on Equity (TTM) i	-0.48%	0.12%
Debt to Equity (MRQ) i	0.01	56.91
Cash & Liquidity
Book Value per Share (MRQ)	$0.01	$37.06
Cash per Share (MRQ)	N/A	$1.98
Operating Cash Flow (TTM) i	$-3,881,392	$251.52M
Levered Free Cash Flow (TTM) i	$-4,301,837	$188.69M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	$0.00

Valuation & Enterprise Metrics Analysis: Regencell Bioscience vs Prestige Consumer

Metric	RGC	PBH
Price Ratios
P/E Ratio (TTM) i	N/A	17.92
Forward P/E i	N/A	16.12
PEG Ratio i	N/A	16.12
Price to Sales (TTM) i	N/A	3.33
Price to Book (MRQ) i	960.00	2.07
Market Capitalization
Market Capitalization i	$6.65B	$3.79B
Enterprise Value i	$6.64B	$4.75B
Enterprise Value Metrics
Enterprise to Revenue i	N/A	4.17
Enterprise to EBITDA i	-1,664.45	12.51
Risk & Other Metrics
Beta i	2.19	0.43
Book Value per Share (MRQ) i	$0.01	$37.06

Financial Statements Comparison: Regencell Bioscience vs Prestige Consumer

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	RGC	PBH
Revenue/Sales i	N/A	$296.52M
Cost of Goods Sold i	N/A	$126.51M
Gross Profit i	N/A	$170.01M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	$100.89M
EBITDA i	N/A	$91.97M
Pre-Tax Income i	N/A	$73.96M
Income Tax i	N/A	$23.83M
Net Income (Profit) i	N/A	$50.13M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	RGC	PBH
Cash & Equivalents i	$2.96M	$97.88M
Total Current Assets i	$8.11M	$448.33M
Total Current Liabilities i	$193,578	$106.62M
Long-Term Debt i	$25,934	$1.04B
Total Shareholders Equity i	$8.22M	$1.83B
Retained Earnings i	$-21.62M	$1.56B
Property, Plant & Equipment i	$84,780	$53.29M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	RGC	PBH
Operating Cash Flow i	N/A	$47.51M
Capital Expenditures i	N/A	$-3.48M
Free Cash Flow i	N/A	$58.37M
Debt Repayment i	N/A	$-2.64M
Common Stock Repurchase i	N/A	$-11.31M

Short Interest & Institutional Ownership Analysis

Metric	RGC	PBH
Shares Short i	2.25M	1.51M
Short Ratio i	1.15	3.44
Short % of Float i	0.02%	0.04%
Average Daily Volume (10 Day) i	311,130	406,280
Average Daily Volume (90 Day) i	1,546,083	411,937
Shares Outstanding i	13.01M	49.51M
Float Shares i	18.43M	48.85M
% Held by Insiders i	0.96%	0.01%
% Held by Institutions i	0.00%	1.08%

Dividend Analysis & Yield Comparison: Regencell Bioscience vs Prestige Consumer

Metric	RGC	PBH
Last 12-Month Dividend i	N/A	$0.00
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	$0.00
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	$0.00
Ex-Dividend Date	N/A	N/A

Regencell Bioscience [RGC] vs Prestige Consumer [PBH] Detailed Stock Comparison